Autophagy stimulation abrogates herpes simplex virus-1 infection

Area of Science:

• Virology
• Immunology
• Cell Biology

Background:

• Herpes simplex virus-1 (HSV-1) establishes lifelong infections and can cause severe conditions like herpetic stromal keratitis, encephalitis, and neonatal disease.
• HSV-1 employs virulence mechanisms, including the suppression of autophagy, a cellular process crucial for innate immunity and viral clearance.
• Understanding HSV-1's interaction with autophagy is vital for developing effective antiviral therapies.

Purpose of the Study:

• To investigate the potential of autophagy inducers as a novel antiviral therapeutic strategy against HSV-1.
• To determine if stimulating autophagy can suppress HSV-1 infection in various cell types.
• To evaluate the impact of autophagy stimulation on cell viability during HSV-1 infection.

Main Methods:

• Treatment of HSV-1 infected cells with various physiological and pharmacological autophagy inducers.
• Assessment of HSV-1 infection levels following autophagy stimulation.
• Evaluation of cell viability to determine the safety of autophagy induction as a therapeutic approach.

Main Results:

• Autophagy stimulation significantly suppressed HSV-1 infection across multiple cell types.
• The observed antiviral effect of autophagy induction occurred without compromising cell viability.
• This demonstrates a direct link between autophagy modulation and the control of HSV-1 replication.

Conclusions:

• Autophagy plays a critical role in regulating HSV-1 infection.
• Stimulating autophagy presents a promising, novel therapeutic strategy for combating HSV-1.
• This research provides proof-of-principle for developing new antiviral treatments targeting the autophagy pathway.